May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland.
Blood pressure
Control
Disease awareness
Hypertension
Screening
Treatment
Journal
European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
5
9
2020
Statut:
ppublish
Résumé
Hypertension remains the most important cardiovascular risk factor in Poland. May Measurement Month is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for blood pressure (BP) screening and demonstrating the potential of the opportunistic BP measurements. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in 146 sites in May 2018. Blood pressure was measured in 6450 subjects (mean age: 41 ± 15 years; 59% females). After multiple imputation, the age and sex standardized systolic and diastolic BP was 126.7/78.4 mmHg in the whole analysed group, 132.8/81.3 mmHg in subjects taking antihypertensive drugs, and 125.7/78.0 mmHg in those not taking any antihypertensive drugs. After multiple imputation, the proportions of subjects with high BP (systolic ≥140 mmHg or diastolic ≥90 mmHg or on treatment for raised BP) were 22.2% in the whole analysed group, 39.2% in subjects taking antihypertensive drugs, and 18.6% those not taking any antihypertensive drugs. Overall, hypertension was present in 32.8% of participants, among them 38.7% were not aware of the disease, 53.1% were taking antihypertensive drugs, and 32.3% had BP controlled to target (<140/90 mmHg). Blood pressure was increasing with increasing body mass index and alcohol intake. Smokers and project participants with diabetes had increased average BP. In conclusion, this project provides additional evidence for a considerable potential for further reduction of cardiovascular risk through improvement in detection and treatment of hypertension in Poland.
Identifiants
pubmed: 32884486
doi: 10.1093/eurheartj/suaa041
pii: suaa041
pmc: PMC7455275
doi:
Types de publication
Journal Article
Langues
eng
Pagination
H108-H111Informations de copyright
Published on behalf of the European Society of Cardiology. © The Author(s) 2020.
Références
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet. 2017 Apr 29;389(10080):1678-1680
pubmed: 28463128
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100
pubmed: 31043891
Arch Med Sci. 2018 Aug;14(5):951-961
pubmed: 30154875
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Arch Med Sci. 2018 Aug;14(5):979-987
pubmed: 30154878